Anne Nallen has 30 years’ experience in the regulation of human and veterinary medicines across global markets. Anne Joined Alexion in August 2020 as Director of Global Regulatory Affairs CMC. Prior to that she headed up the Regulatory CMC development of the first monoclonal antibody for companion animals to be approved by FDA. She has held Senior Leadership positions across all elements of the regulatory function and has extensive experience in the licensing of both large and small molecule products.
She was awarded Fellowship status by TOPRA in 2020.
She is a past President of TOPRA and a former Vice-Chair of Access VetMed (formerly EGGVP). She has a certification in Company Direction from the Institute of Directors and a Qualified Person’s qualification from Trinity College Dublin.